Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
Public ClinicalTrials.gov record NCT00355121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Immunogenicity and Safety of Meningococcal (Serogroups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®) in Children Aged 4 to 6 Years in the US When Administered Concomitantly With a Fifth Dose Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the immunogenicity and safety of the concomitant administration of Menactra® vaccine and DAPTACEL® vaccine. The main objectives are: Immunogenicity: To evaluate the antibody responses to both vaccines when Menactra vaccine is given concomitantly with DAPTACEL® compared to when either vaccine is given alone. Safety: To evaluate the rate of local and systemic reactions when DAPTACEL® and Menactra vaccines are administered concomitantly compared to when each vaccine is given alone.
Study identification
- NCT ID
- NCT00355121
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 882 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 4 Years to 7 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2006 (Type not available)
- Primary completion
- Jun 2009 (Actual)
- Completion
- Jul 2009 (Actual)
- Last update posted
- Aug 24, 2011
2006 – 2009
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Boulder | Colorado | 80304 | — |
| Not listed | Atlanta | Georgia | 30322 | — |
| Not listed | Layton, UT 84041 | Georgia | 30062 | — |
| Not listed | Bardstown | Kentucky | 40004 | — |
| Not listed | Woburn | Massachusetts | 01801 | — |
| Not listed | Bridgeton | Missouri | 63044 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | Albuquerque | New Mexico | 87108 | — |
| Not listed | Rochester | New York | 14620 | — |
| Not listed | Syracuse | New York | 13210 | — |
| Not listed | Akron | Ohio | 44308 | — |
| Not listed | Cincinnati | Ohio | 45229 | — |
| Not listed | Columbus | Ohio | 43205 | — |
| Not listed | University Heights | Ohio | 44118 | — |
| Not listed | Pittsburgh | Pennsylvania | 15241 | — |
| Not listed | Sellersville | Pennsylvania | 18960 | — |
| Not listed | Kingsport | Tennessee | 37660 | — |
| Not listed | Layton | Utah | 84041 | — |
| Not listed | Ogden | Utah | 84405 | — |
| Not listed | Pleasant Grove | Utah | 84062 | — |
| Not listed | Provo | Utah | 84604 | — |
| Not listed | Salt Lake City | Utah | 84123 | — |
| Not listed | South Jordan | Utah | 84095 | — |
| Not listed | Norfolk | Virginia | 23510 | — |
| Not listed | Spokane | Washington | 99220 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00355121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 24, 2011 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00355121 live on ClinicalTrials.gov.